 - Symptomatic or untreated Central nervous system CNS disease, Subjects with a history of CNS disease leukemia, lymphoma or myeloma are permitted to enrol if they have previously received appropriate therapy and CNS remission has been documented. Subject with primary CNS lymphoma defined as isolated CNS lymphoma without systemic involvement are excluded from study. 